Cargando…
Design and Optimization of Rivaroxaban-Cyclodextrin-Polymer Triple Complex Formulation with Improved Solubility
PURPOSE: This study aimed to ensure the convenience of administration and reproducibility of efficacy, regardless of the meal, by improving the solubility of rivaroxaban (RIV). METHODS: RIV is a non-vitamin K antagonist oral anticoagulants that exhibits a coagulation effect by directly inhibiting co...
Autores principales: | Kang, Ji-Hyun, Lee, Ji-Eun, Jeong, So-Jeong, Park, Chun-Woong, Kim, Dong-Wook, Weon, Kwon-Yeon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767707/ https://www.ncbi.nlm.nih.gov/pubmed/36561308 http://dx.doi.org/10.2147/DDDT.S389884 |
Ejemplares similares
-
Effect of hydrophilic polymers on the solubility and dissolution enhancement of rivaroxaban/beta-cyclodextrin inclusion complexes
por: Khan, Waqas Haider, et al.
Publicado: (2023) -
Effects of Polymers on the Drug Solubility and Dissolution Enhancement of Poorly Water-Soluble Rivaroxaban
por: Choi, Min-Jong, et al.
Publicado: (2022) -
The Development and Optimization of Hot-Melt Extruded Amorphous Solid Dispersions Containing Rivaroxaban in Combination with Polymers
por: Lee, Jong-Hwa, et al.
Publicado: (2021) -
Bicalutamide Anticancer Activity Enhancement by Formulation of Soluble Inclusion Complexes with Cyclodextrins
por: De Gaetano, Federica, et al.
Publicado: (2022) -
Solubility of Cyclodextrins and Drug/Cyclodextrin Complexes
por: Saokham, Phennapha, et al.
Publicado: (2018)